This Article Full Text (PDF) All Versions of this Article: 0269881106067765v1 20/6/863    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shastri, M. Articles by Sabaratnam, M. Search for Related Content PubMed PubMed Citation Articles by Shastri, M. Articles by Sabaratnam, M. Social Bookmarking                         What's this?

Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series

Staff Grade Psychiatrist, Ealing Community Team for People with Intellectual Disabilities, Hanwell, London, UK

Lakshmiramana Alla

Staff Grade Psychiatrist, Three Bridges Regional Secure Unit, Southall, London, UK

Manga Sabaratnam

Consultant Psychiatrist, Ealing Community Team for People with Intellectual Disabilities, Hanwell, London, UK

People with intellectual disabilities may be at greater risk of developing movement disorders as a consequence of their underlying neurological damage, especially when they are treated with typical antipsychotic agents. Aripiprazole is a novel antipsychotic quinolone derivative that has been approved for the treatment of schizophrenia in adults. However, there are few reports on the use of aripiprazole in people with intellectual disabilities. Herein, we report on the use of aripiprazole in five individuals with intellectual disabilities and psychotic illness (four cases) or challenging behaviour (one case). Four of the five patients had an additional diagnosis of schizophrenia and one had autism spectrum disorder and challenging behaviour. Issues related to the usefulness of aripiprazole in the management of schizophrenia and challenging behaviour in people with intellectual disabilities are also discussed. Aripiprazole was well tolerated and effective in each of the cases and appears to be a safe and efficacious alternative in the management of patients with both intellectual disabilities and schizophrenia. It can also be a useful treatment option in the management of challenging behaviour, especially when it is used as a part of a biopsychosocial approach.

Key Words: aripiprazole • schizophrenia • intellectual disability • psychotic disorders • behavioural disorders • challenging behaviour

This version was published on November 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 6, 863-867 (2006)
DOI: 10.1177/0269881106067765


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. M Stachnik and C. Nunn-Thompson Use of Atypical Antipsychotics in the Treatment of Autistic Disorder Ann. Pharmacother., April 1, 2007; 41(4): 626 - 634. [Abstract] [Full Text] [PDF]